Department of Dermatology and Venereal Diseases, Dezhou People's Hospital, Dezhou, China.
Department of Dermatology and Venereal Diseases, Jinan City People's Hospital, Jinan, China.
J Trace Elem Med Biol. 2020 Dec;62:126570. doi: 10.1016/j.jtemb.2020.126570. Epub 2020 Jun 5.
Antioxidant status is considered as important factor in the pathogenesis of vitiligo. However, there are controversial findings about serum status of antioxidants in vitiligo patients. The purpose of this study was to systematically review the evidences comparing the serum levels of antioxidant vitamins and minerals between vitiligo patients and controls, and performing meta-analysis of the results.
A comprehensive search was performed for studies comparing the serum status of antioxidant vitamins and minerals using following databases since inception up to 30 April 2020; PubMed, EMBASE, Scopus, and Web of Science. Data extraction was done by two independent reviewers. The data was pooled for serum level of each antioxidant comparing between vitiligo and control groups.
Thirteen studies were included in this systematic review. The serum level of vitamin A, C, E, selenium, zinc and copper were compared between vitiligo patients and controls in these studies. Eleven studies including 570 vitiligo cases and 580 controls were included in the meta-analysis. Serum vitamin A and copper level in vitiligo patients were only evaluated in single studies and not included in meta-analysis. Based on fixed effect model, there were no statistical difference between two groups regarding serum vitamin C (OR = 1.17, 95 % CI, 0.74-1.84, P = 0.495), and vitamin E (OR = 0.61, 95 % CI, 0.30-1.25, P = 0.180). Higher serum zinc can decrease the risk of vitiligo based on sensitivity analysis of the results. (OR = 0.29, 95 % CI 0.15-0.54, P < 0.001). Higher serum selenium level significantly increased the risk of vitiligo (OR = 4.31, 95 % CI, 2.72-6.81, P < 0.001). Vitamin A was not significantly different in two reported groups (6.35 ± 1.53 vs 6.77 ± 1.46 μg/mL, P > 0.05). Copper was significantly higher in vitiligo patients compared to controls (129 ± 33 vs 99 ± 19 μg /100 mL, P = 0.002).
The current meta-analysis of data on serum level of most studied antioxidants (vitamin C, vitamin E, zinc and selenium) in patients suffering vitiligo showed that higher serum selenium (OR = 4.31) and lower zinc level (OR = 0.29) can increased the risk of vitiligo. Potential mechanism associated with preventive effects of zinc and the depigmentation effect of selenium should be more elucidated in further studies.
抗氧化状态被认为是白癜风发病机制中的重要因素。然而,关于白癜风患者血清抗氧化剂状态的研究结果存在争议。本研究的目的是系统地综述比较白癜风患者和对照组血清抗氧化维生素和矿物质水平的证据,并对结果进行荟萃分析。
自成立以来,我们使用以下数据库全面搜索了比较使用抗氧化维生素和矿物质的血清水平的研究:PubMed、EMBASE、Scopus 和 Web of Science。两名独立的评审员进行了数据提取。将血清水平数据汇总比较了白癜风组和对照组之间的每种抗氧化剂。
本系统评价共纳入 13 项研究。这些研究比较了白癜风患者和对照组的血清维生素 A、C、E、硒、锌和铜水平。纳入了 11 项研究,包括 570 例白癜风病例和 580 例对照,进行了荟萃分析。基于固定效应模型,两组间血清维生素 A 和铜水平无统计学差异(OR=1.17,95%CI,0.74-1.84,P=0.495)和维生素 E(OR=0.61,95%CI,0.30-1.25,P=0.180)。基于敏感性分析的结果,更高的血清锌可以降低白癜风的风险。(OR=0.29,95%CI 0.15-0.54,P<0.001)。更高的血清硒水平显著增加了白癜风的风险(OR=4.31,95%CI,2.72-6.81,P<0.001)。两组报道的维生素 A 无显著差异(6.35±1.53 vs 6.77±1.46μg/mL,P>0.05)。与对照组相比,白癜风患者的铜明显升高(129±33 与 99±19μg/100mL,P=0.002)。
目前荟萃分析了白癜风患者血清中大多数研究抗氧化剂(维生素 C、维生素 E、锌和硒)水平的数据,结果显示,更高的血清硒(OR=4.31)和更低的锌水平(OR=0.29)会增加白癜风的风险。应在进一步的研究中更深入地阐明与锌的预防作用和硒的退色作用相关的潜在机制。